Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBIX | ZTS | TAK | UTHR | STVN |
| Company | Neurocrine Bioscienc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Stevanato Group S.P.A. |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NYSE |
| Open | 140.00 | 168.71 | 13.21 | 266.00 | 21.00 |
| High | 141.00 | 169.72 | 13.30 | 269.81 | 22.40 |
| Low | 138.02 | 168.29 | 13.17 | 265.29 | 20.55 |
| Last | 137.68 | 169.83 | 13.28 | 265.70 | 21.00 |
| Change | -1.98 | +1.70 | -0.09 | -0.35 | -0.10 |
| % Change | -1.42% | +1.01% | -0.67% | -0.13% | -0.47% |
| Volume | 114,241 | 678,196 | 645,437 | 102,946 | 1,201,725 |
| 20-Day Average Volume | 760,307 | 4,229,073 | 1,484,596 | 561,522 | 614,627 |
| Previous Close | 139.66 | 168.13 | 13.37 | 266.05 | 21.10 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 137.56 | 158.03 | 13.22 | 246.08 | 26.94 |
| 20-Day Raw Stochastic | 56.20% | 89.35% | 75.71% | 92.95% | 9.59% |
| 20-Day Relative Strength | 50.93% | 54.63% | 44.59% | 66.83% | 27.08% |
| Weighted Alpha | +42.18 | -8.72 | -18.86 | +29.38 | -35.68 |
| Today's Opinion | 88% Buy | 40% Sell | 88% Sell | 88% Buy | 100% Sell |
| Previous Opinion | 88% Buy | 40% Sell | 88% Sell | 88% Buy | 100% Sell |
| Last Month's Opinion | 72% Buy | 56% Sell | 96% Sell | 64% Buy | 40% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.49% since 05/03/24 | +1.34% since 05/03/24 | -0.52% since 05/03/24 | +1.76% since 05/03/24 | -20.79% since 05/03/24 |
| Low | 138.15 on 05/08/24 | 161.00 on 05/08/24 | 12.77 on 05/09/24 | 256.08 on 05/06/24 | 20.01 on 05/09/24 |
| High | 143.86 on 05/07/24 | 172.23 on 05/07/24 | 13.47 on 05/09/24 | 269.81 on 05/10/24 | 28.08 on 05/07/24 |
| 1-Month | |||||
| %Chg | +0.38% since 04/10/24 | +3.74% since 04/10/24 | -1.99% since 04/10/24 | +12.30% since 04/10/24 | -27.76% since 04/10/24 |
| Low | 130.13 on 04/19/24 | 144.80 on 04/22/24 | 12.77 on 05/09/24 | 230.39 on 04/16/24 | 20.01 on 05/09/24 |
| High | 145.22 on 05/01/24 | 172.23 on 05/07/24 | 13.60 on 04/11/24 | 269.81 on 05/10/24 | 29.82 on 04/11/24 |
| 3-Month | |||||
| %Chg | +4.77% since 02/09/24 | -14.20% since 02/09/24 | -6.60% since 02/09/24 | +25.76% since 02/09/24 | -35.74% since 02/09/24 |
| Low | 129.15 on 03/01/24 | 144.80 on 04/22/24 | 12.77 on 05/09/24 | 210.64 on 02/12/24 | 20.01 on 05/09/24 |
| High | 148.37 on 03/21/24 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 269.81 on 05/10/24 | 34.00 on 03/01/24 |
| 6-Month | |||||
| %Chg | +29.34% since 11/10/23 | -0.01% since 11/10/23 | -2.85% since 11/10/23 | +19.83% since 11/10/23 | -26.77% since 11/10/23 |
| Low | 106.85 on 11/13/23 | 144.80 on 04/22/24 | 12.77 on 05/09/24 | 208.62 on 02/08/24 | 20.01 on 05/09/24 |
| High | 148.37 on 03/21/24 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 269.81 on 05/10/24 | 34.73 on 02/07/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 14,054,964 | 76,716,888 | 42,313,872 | 11,800,911 | 6,235,895 |
| Shares Outstanding, K | 100,637 | 456,295 | 3,164,837 | 44,356 | 295,540 |
| Annual Sales | 1,887,100,000 | 8,544,000,000 | 29,803,340,000 | 2,327,500,000 | 1,174,680,000 |
| Annual Net Income | 249,700,000 | 2,344,000,000 | 2,345,930,000 | 984,800,000 | 157,620,000 |
| Last Quarter Sales | 515,300,000 | 2,190,000,000 | 7,556,070,000 | 677,700,000 | 345,420,000 |
| Last Quarter Net Income | 43,400,000 | 599,000,000 | 718,900,000 | 306,600,000 | 48,700,000 |
| 60-Month Beta | 0.28 | 0.86 | 0.56 | 0.54 | 0.76 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.42 on 05/01/24 | 1.38 on 05/02/24 | 0.51 on 02/01/24 | 6.17 on 05/01/24 | 0.08 on 05/09/24 |
| Latest Earnings Date | 05/01/24 | 05/02/24 | 05/09/24 | 05/01/24 | 05/09/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 38.30 | 30.60 | 6.70 | 12.34 | 43.40 |